Abstract

The present invention describes a hydraulic cement composition, process and use thereof, wherein the composition comprises a hydraulic cement composition with increased resistance against carbon dioxide (CO2) for application in reservoirs such as oil and gas and carbon capture and storage (CCS) wells; with improved performance of cement paste formulations as a material for application in primary, secondary cementing, recovery and/or plugging operations, of reservoirs/wells that operate with high CO2 content; as a technological alternative to guarantee the integrity of wells in CO2-rich environments for long periods of time, without any additional intervention to the already current operational procedures for cementing wells, and with cost reduction in relation to class G cement (currently, the main raw material); and sufficient chemical resistance to carry out enhanced oil (EOR) and gas (EGR) recovery by injecting high levels of CO2, increasing reservoir pressure throughout the extraction period of hydrocarbon reservoirs.

IPC Classes  ?

• C09K 8/493 - Additives for reducing or preventing gas migration
• C04B 7/13 - Mixtures thereof with inorganic cementitious materials, e.g. Portland cements
• C04B 7/40 - DehydratingForming, e.g. granulating
• C04B 7/52 - Grinding
• C04B 28/02 - Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing hydraulic cements other than calcium sulfates
• C04B 111/00 - Function, property or use of the mortars, concrete or artificial stone
• C04B 111/22 - Carbonation resistance
• C09K 8/42 - Compositions for cementing, e.g. for cementing casings into boreholesCompositions for plugging, e.g. for killing wells

Abstract

2, increasing reservoir pressure throughout the extraction period of hydrocarbon reservoirs.

IPC Classes  ?

• C04B 7/13 - Mixtures thereof with inorganic cementitious materials, e.g. Portland cements
• C04B 7/40 - DehydratingForming, e.g. granulating
• C04B 7/52 - Grinding
• C04B 28/02 - Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing hydraulic cements other than calcium sulfates
• C09K 8/42 - Compositions for cementing, e.g. for cementing casings into boreholesCompositions for plugging, e.g. for killing wells
• C09K 8/493 - Additives for reducing or preventing gas migration
• C04B 111/00 - Function, property or use of the mortars, concrete or artificial stone
• C04B 111/22 - Carbonation resistance

Abstract

The present invention relates to an antimicrobial/microbicidal composition for topical/external and preventative use against infectious agents, useful in healthcare environments, such as hospitals, clinics and/or aesthetic centres, commercial environments and/or industrial environments. Said composition comprises antimicrobial agents and colouring agents, inter alia, that demonstrate its presence, coverage, continued presence and antimicrobial activity; it can be seen and, as time passes, indicates when reapplication is necessary. In addition, it contains hydrating ingredients that prevent the skin from drying out.

IPC Classes  ?

• A61K 47/00 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient
• A61K 31/00 - Medicinal preparations containing organic active ingredients
• A61K 31/19 - Carboxylic acids, e.g. valproic acid
• A61K 31/755 - Polymers containing halogen
• A61K 36/61 - Myrtaceae (Myrtle family), e.g. teatree or eucalyptus

Abstract

Equipment and method for depositing sprayed microparticulate materials. The present invention describes equipment and a method for coating metal material with particulate material by sputtering. The main advantages of this invention are sterile and semi-continuous production, precision control of the thickness of the coating layer, and a reduction in environmental and occupational hazards, given that the method is semi-automated. The present invention is in particular used in the manufacture of raw materials for use in the medical field.

IPC Classes  ?

• C23C 14/34 - Sputtering
• C23C 14/56 - Apparatus specially adapted for continuous coatingArrangements for maintaining the vacuum, e.g. vacuum locks
• C23C 14/58 - After-treatment

Abstract

The present invention describes compounds, the use of compounds in the preparation of a pharmaceutical composition, and a pharmaceutical composition comprising the compounds according to formula A, neutral or ionized derivatives or analogues thereof, for senolytic prevention and/or therapy purposes. Specifically, the present invention comprises the compounds of formula A, neutral or ionized derivatives or analogues thereof, for senolytic prevention and/or therapy purposes, based on selective apoptosis of senescent cells.

IPC Classes  ?

• C07D 493/00 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
• C07D 311/00 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
• C07D 311/58 - Benzo [b] pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulfur atoms in position 2 or 4
• A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
• A61P 35/00 - Antineoplastic agents
• A61P 39/00 - General protective or antinoxious agents
• A61P 39/06 - Free radical scavengers or antioxidants

Abstract

The invention relates to a method for diffusing dopants for the production of solar cells with diffusion of p+ dopant (boron, aluminium, gallium, etc.) and diffusion of phosphorus in crystalline silicon wafers and annealing in the same thermal step, in order to reduce the number of steps and amount of time involved in the production of solar cells, and as a result, to reduce the cost of production. The invention pertains to the fields of solar energy conversion devices, specifically solar cells.

IPC Classes  ?

• H01L 31/18 - Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof
• H01L 21/22 - Diffusion of impurity materials, e.g. doping materials, electrode materials, into, or out of, a semiconductor body, or between semiconductor regionsRedistribution of impurity materials, e.g. without introduction or removal of further dopant

Abstract

The present invention describes a composition of volatile Piper hispidinervum extracts and essential oils rich in terpinolene, which have low toxicity and are produced from renewable raw materials. The present invention also describes the use of said phytosanitary composition for combating ticks (Rhipicephalus (Boophilus) microplus), which mainly affect bovine cattle. The present invention pertains to the fields of veterinary medicine, botanics and pharmacy.

IPC Classes  ?

• A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
• A01N 65/08 - Magnoliopsida [dicotyledons]
• A01N 65/36 - Rutaceae [Rue family], e.g. lime, orange, lemon, corktree or pricklyash
• A01N 65/22 - Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
• A01N 43/30 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atom with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3 with two oxygen atoms in positions 1,3, condensed with a carbocyclic ring

Abstract

The present invention describes the antimicrobial action of azo-stilbenoids. The present invention pertains to the fields of microbiology and organic chemistry.

IPC Classes  ?

• A61K 47/16 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen
• A61K 31/702 - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
• A61P 31/04 - Antibacterial agents

Abstract

The present invention describes novel azo-stilbenoids as leishmanicidal agents. The present invention relates to the fields of organic synthesis and clinical pharmacology.

IPC Classes  ?

• A61K 31/655 - Azo (—N=N—), diazo (=N2), azoxy (N—O—N or N(=O)—N), azido (—N3) or diazoamino (—N=N—N) compounds
• A61P 33/02 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
• C07C 245/08 - Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene

Abstract

The present invention belongs to the fields of material engineering and mechanical engineering, and describes a laminated composite material (1) produced from Raphia Hookeri, a micronized composite material (2) produced from Raphia Hookeri, a structural panel (3) produced with the laminated composite material (1) and a structural panel (3) produced from the micronized composite material (2). The present invention provides a solution in the field of structural panels, having the advantages of reduced density, thermal insulation, acoustic insulation and fire-proofing, besides a solution for using waste products from Raphia Hookeri.

IPC Classes  ?

• B29B 7/92 - Wood chips or wood fibres
• B29C 70/08 - Fibrous reinforcements only comprising combinations of different forms of fibrous reinforcements incorporated in matrix material, forming one or more layers, with or without non-reinforced layers
• B32B 23/00 - Layered products essentially comprising cellulosic plastic substances
• B32B 27/02 - Layered products essentially comprising synthetic resin in the form of fibres or filaments
• B32B 27/36 - Layered products essentially comprising synthetic resin comprising polyesters
• B32B 27/38 - Layered products essentially comprising synthetic resin comprising epoxy resins
• B32B 15/08 - Layered products essentially comprising metal comprising metal as the main or only constituent of a layer, next to another layer of a specific substance of synthetic resin
• B32B 15/04 - Layered products essentially comprising metal comprising metal as the main or only constituent of a layer, next to another layer of a specific substance
• B32B 21/13 - Layered products essentially comprising wood, e.g. wood board, veneer, wood particle board all layers being exclusively wood
• B27L 11/08 - Manufacture of wood shavings, chips, powder, or the likeTools therefor of wood fibres, e.g. produced by tearing
• B27N 3/04 - Manufacture of substantially flat articles, e.g. boards, from particles or fibres from fibres
• C04B 16/02 - Cellulosic materials
• C04B 18/24 - Vegetable refuse, e.g. rice husks, maize-ear refuseCellulosic materials, e.g. paper
• C04B 18/26 - Wood, e.g. sawdust, wood shavings
• C04B 16/06 - Macromolecular compounds fibrous
• D01F 2/28 - Monocomponent artificial filaments or the like of cellulose or cellulose derivativesManufacture thereof from cellulose derivatives from organic cellulose esters or ethers, e.g. cellulose acetate
• E04B 1/62 - Insulation or other protectionElements or use of specified material therefor
• E04B 1/64 - Insulation or other protectionElements or use of specified material therefor for making damp-proofProtection against corrosion
• E04C 2/16 - Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials of wood, fibres, chips, vegetable stems, or the likeBuilding elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials of plasticsBuilding elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials of foamed products of fibres, chips, vegetable stems, or the like
• E04C 2/12 - Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials of wood, fibres, chips, vegetable stems, or the likeBuilding elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials of plasticsBuilding elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials of foamed products of solid wood
• F25D 23/08 - Parts formed wholly or mainly of plastics materials

Abstract

The present invention describes a method for precisely determining the maximum execution time of a critical task of an embedded system based on a multicore processor. For that purpose, the use of a specific hardware is proposed, with the function of analysing and timing the execution of the task. More specifically, the purpose of the system is to ensure that the maximum response time of the critical function of the program executed by the processor does not exceed a preset limit, and should this critical task not be completed before the limit, the system disables the other processor cores, keeping in operation only the core that is executing the critical task. The specific hardware, which is implemented with a watchdog system, is configured with information relevant to the execution of the critical program in isolation (that is to say, in a processor with a single core), with reduced computational complexity and extreme feasibility, monitoring the execution time of the task without needing to know what is the maximum value of the execution time of this program in an environment with multiple microprocessor cores. The present invention pertains to the fields of eletronics and computer science.

IPC Classes  ?

• G06F 9/48 - Program initiatingProgram switching, e.g. by interrupt
• G06F 9/50 - Allocation of resources, e.g. of the central processing unit [CPU]
• G06F 9/46 - Multiprogramming arrangements
• G06F 9/44 - Arrangements for executing specific programs
• G06F 9/00 - Arrangements for program control, e.g. control units
• G06F 11/00 - Error detectionError correctionMonitoring
• G06F 15/76 - Architectures of general purpose stored program computers

Abstract

The present invention describes a compound of formula 1, a method for producing the compound, a composition, a use of the compound for preparing a medicinal drug for treating a disorder caused by bacteria of the genus Mycobacterium and a method for treating a disorder caused by bacteria of the genus Mycobacterium. In one embodiment, the bacteria is Mycobacterium tuberculosis resistant to at least one antibiotic selected from the group of isoniazid and rifampicin. The present invention pertains to the fields of pharmacy, medicinal chemistry and organic synthesis.

IPC Classes  ?

• C07D 215/22 - Oxygen atoms attached in position 2 or 4
• A61K 31/47 - QuinolinesIsoquinolines
• A61P 31/06 - Antibacterial agents for tuberculosis

Abstract

The use of at least one compound of formula I or II or pharmaceutically acceptable salts thereof, for preparing a pharmaceutical composition that acts by inhibiting the phosphorylase uridine enzyme, and the use of the compounds for preparing a pharmaceutical composition that acts by inhibiting the human phosphorylase uridine enzyme, which can be optionally used in combination with at least one antineoplastic, wherein the inhibition increases the effectiveness of antineoplastic and decreases the side effects caused by the administration of antineoplastics.

IPC Classes  ?

• A61K 31/4412 - Non-condensed pyridinesHydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
• A61K 31/513 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
• A61K 31/4545 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine

Abstract

The present invention pertains to the field of medical bioengineering and medicine, and provides an olfactory stimulation system compatible with magnetic resonance environments in that it comprises in its structure elements made of diamagnetic and/or polymeric materials, allowing the valve to be arranged near the sample storage means, and the latter to be arranged near the delivery means or the assessed individual, which reduces transportation delays, achieving more precise results and greater portability. The present invention further provides a method for detecting response signals to olfactory stimuli, with a reduced response time between the moment of release, adjustment or blending of aromatic samples, and the moment when the stimuli are recorded by the individual exposed to the sample.

IPC Classes  ?

• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• A61L 9/03 - Apparatus therefor
• A61M 11/00 - Sprayers or atomisers specially adapted for therapeutic purposes
• A61M 15/00 - Inhalators
• A61B 5/055 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fieldsMeasuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging

Abstract

The present invention describes a load-transportation vehicle (10) and a packaging and discharge method for such a load-transportation vehicle (10). More specifically, the present invention comprises the installation of an inflatable bag (12) over the floor of a load compartment (11). Said bag (12) is pressurized prior to loading the compartment (11), the pressurization pressure being a function of the density of the load and of the total volume of load to be transported. During loading, the inflatable bag (12) is compressed and flattened, freeing up the useable volume of the compartment (11). Discharge takes place in two steps: first, the material is unloaded under gravity until such time as the pressure inside the bag (12) becomes greater than the pressure on the outer surface thereof; next, the second stage begins, in the course of which the bag (12) expands and guides the material inside the compartment (11) to the unloading areas (15).

IPC Classes  ?

• B65D 88/58 - Large containers characterised by means facilitating filling or emptying by displacement of walls
• B65D 25/38 - Devices for discharging contents
• B65D 88/62 - Large containers characterised by means facilitating filling or emptying by displacement of walls of internal walls the walls being deformable

Abstract

The present invention provides a composition for modulating MARCH-I, MHC II and/or CD86 in the cells of an ex vivo organ, that is to say an organ taken from a donor for subsequent transplantation in a recipient. In one embodiment, the composition comprises one or more organ preservation solutions in combination with an Hsp. In another embodiment, the composition of the invention comprises Hsp70 and/or one or more synthetic Hsp70-derived peptides. The composition of the invention provides preservation while at the same time reducing rejection of an organ, thus offering many advantages and solving various relevant technical problems: not only preserving the useful life of the organ but also initiating a process in the organ which inhibits acute rejection; lengthening the useful life of the organ in vivo; having local immunomodulating effects in the recipient; having an indirect impact on the quality of life of the transplant recipient by necessitating fewer immunossuppressive medications; inducing the activity of regulatory T cells (which are acknowledged to be immunosuppressors), reducing the expression of MHC molecules in the graft, reducing alloreactive expression in the recipient's lymph nodes, and lengthening the survival of the graft in the recipient.

IPC Classes  ?

• A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
• A61K 38/10 - Peptides having 12 to 20 amino acids
• A01N 1/02 - Preservation of living parts

Abstract

The present invention relates to the fields of engineering, fluid mechanics and geology. More specifically, the present invention provides a device for collecting and/or sampling fluids, especially gases, actuated remotely for very deep subaquatic applications, for collecting gases and/or fluids in general, such that only the fluid of interest is collected, and also a method for collecting fluids/gases using said device.

IPC Classes  ?

• G01N 1/10 - Devices for withdrawing samples in the liquid or fluent state
• G01N 1/22 - Devices for withdrawing samples in the gaseous state

Abstract

The present invention describes a new adult mesenchymal stem cell culture method comprising the steps of: (a) incubating degenerated ex-vivo tissues in a culture medium; (b) isolating adult mesenchymal stem cells from the medium obtained in step (a); and (c) cultivating the adult mesenchymal stem cells isolated in step (b). The method further dispenses with the mechanical and enzymatic dissociation steps that are usually applied in the prior art. The present invention also provides an adult mesenchymal stem cell culture kit comprising: (a) a container made of an anti-adhesive material; (b) a suitable culture medium; and (c) a suitable cell culture container. The present invention additionally describes a composition comprising the adult mesenchymal stem cells obtained by the above-mentioned method, and a pharmaceutically acceptable carrier. The present invention further describes the use of the adult mesenchymal stem cells obtained by the above-mentioned method for producing a composition for the treatment of diskopathies involving degenerated intervertebral disks.

IPC Classes  ?

• C12N 5/0775 - Mesenchymal stem cellsAdipose-tissue derived stem cells
• A61K 35/545 - Embryonic stem cellsPluripotent stem cellsInduced pluripotent stem cellsUncharacterised stem cells
• A61P 19/00 - Drugs for skeletal disorders

Abstract

The present invention relates to a method for synthesizing lanthanide-based coordination compounds using exclusively ultra-sound as the energy source. More specifically, the method comprises the following steps: addition of a chelating agent to an aqueous medium while applying ultra-sound; and addition of lanthanide oxide to the aqueous medium while applying ultra-sound. In addition, the present invention describes new Gd(III) complexes. The present invention pertains to the chemistry field.

IPC Classes  ?

• A61K 103/34 - Gadolinium
• A61K 51/06 - Macromolecular compounds
• A61K 49/06 - Nuclear magnetic resonance [NMR] contrast preparationsMagnetic resonance imaging [MRI] contrast preparations
• A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
• C07C 229/16 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
• A61B 5/055 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fieldsMeasuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging

Abstract

The present invention describes the use of at least one compound of formula (I) or (II), or pharmaceutically acceptable salts thereof, for preparing a pharmaceutical composition that acts by inhibiting the uridine phosphorylase enzyme. Specifically, the present invention comprises the use of said compounds for preparing a pharmaceutical composition that acts by inhibiting the human uridine phosphorylase enzyme, which can be optionally used in combination with at least one antineoplastic, wherein said inhibition increases the effectiveness of antineoplastics and decreases the side effects caused by the administration of antineoplastics.

IPC Classes  ?

• A61K 31/4412 - Non-condensed pyridinesHydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
• A61K 31/505 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim
• A61P 35/00 - Antineoplastic agents

Abstract

The present invention describes new compounds for binding and/or inhibiting enzymes in microorganisms. In one embodiment, the compounds of the present invention are used to inhibit the 2-trans-enoyl-ACP (CoA) reductase enzyme in microorganisms, and are therefore useful as antimicrobial agents.

IPC Classes  ?

• C07D 215/02 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
• C07D 333/02 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
• C07D 285/12 - 1,3,4-ThiadiazolesHydrogenated 1,3,4-thiadiazoles
• C07D 277/10 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
• A61K 31/47 - QuinolinesIsoquinolines
• A61K 31/433 - Thiadiazoles
• A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings
• A61K 31/4245 - Oxadiazoles
• A61P 31/06 - Antibacterial agents for tuberculosis

Abstract

The present invention describes the use of biopolymeric membranes for producing prostheses, cardiovascular prostheses comprising biopolymeric tubes, and methods for producing the same. In a preferred embodiment, the biopolymeric membranes and/or tubes of the present invention comprise polycaprolactone-based polyurethane. The membranes and tubes of the present invention exhibit technical advantages in comparison with commercially available vascular prostheses, such as those made of PTFE and Dacron.

IPC Classes  ?

• A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
• A61F 2/06 - Blood vessels
• C08G 18/42 - Polycondensates having carboxylic or carbonic ester groups in the main chain

Abstract

The present invention provides the use of the HspBP1 protein or portion thereof in preparing an antitumour pharmaceutical composition, the combination thereof with one or more chemotherapeutic agents being optional. The following are also disclosed: a gene construct for expressing said binder, a production process, a process for evaluating tumour cells, and a method of sensitization of tumours to chemotherapeutic drugs. The invention also provides a novel in vivo and in vitro experimental model for developing/evaluating antitumour agents. The pharmaceutical compositions of the invention provide antitumour activity and are highly specific for neoplastic cells, resulting in less cytotoxicity for cells with normal cell division. These and other advantages of the invention characterize a solution for the inconveniences of the currently known chemotherapeutic treatments.

IPC Classes  ?

• C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
• A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof

Abstract

The present invention relates to the field of communication and provides an apparatus and system for synchronized display of visual information and audio information to a user. The invention also allows interaction between the user and the reproduced content, in such a manner that the reproduction of the visual information occurs dynamically in a content‑display region (4.1). The visual information is updated in synchronization with the audio information and the proportion of the quantity of audio and/or video information reproduced, illustrated by means of the gradual filling (8) of a "time line" region (6).

IPC Classes  ?

• H04N 21/431 - Generation of visual interfacesContent or additional data rendering

Abstract

The present invention describes novel and inventive enzymatic inhibiting compounds in microorganisms. In a preferred embodiment, the compounds of the present invention are used to inhibit the 2-trans-enoyl-ACP (CoA) reductase enzyme in microorganisms.

IPC Classes  ?

• C07D 215/02 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
• C07D 277/28 - Radicals substituted by nitrogen atoms
• A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
• A61K 31/381 - Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
• A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

The present invention relates to a furnace and method for diffusing dopants into or oxidising wafers made of silicon or another semiconductor material. Said furnace is an apparatus with a non-tubular quartz or SiC processing chamber with a square or rectangular cross-section, depending on the dimensions and number of the silicon wafers. The volume of the chamber is smaller than that of tube furnaces, allowing the consumption of high-purity gases and electricity to be reduced. The system for charging the wafers into and removing the wafers from the processing chamber and for controlling the high-purity gases and temperature is automated. In addition, the present invention describes a method for diffusing dopants into and/or oxidising wafers made of silicon or another semiconductor using the furnace.

IPC Classes  ?

• H01L 21/02 - Manufacture or treatment of semiconductor devices or of parts thereof

Abstract

The present invention describes a new method for manufacturing solar cells from silicon wafers by diffusion of boron (or another p-type dopant) and phosphorus (or another n-type dopant) into these wafers, a silicate layer being used to protect the face containing boron (or another p-type dopant) from the diffusion of phosphorus (or another n-type dopant). The thermal step for growing the silicon oxide layer and the use of a resin for protecting one of the faces while the oxides are etched with hydrofluoric acid are dispensed with. The invention therefore is advantageous in that it dispenses with the use of photosensitive resin, buffering hydrofluoric acid and acetone, and with at least four steps of solar cell manufacturing methods. It thus reduces manpower/hours and the consumption of electricity, high-purity gases and chemicals, thus lowering production costs in comparison with conventional methods.

IPC Classes  ?

• H01L 31/18 - Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof
• H01L 21/02 - Manufacture or treatment of semiconductor devices or of parts thereof

Abstract

The present invention provides a step of the method for producing solar cells that increases minority carrier lifetime and produces solar cells with increased efficiency. In the process according to the invention, gettering is obtained during aluminium diffusion by a strict control of heating and cooling rates, which are dependent on the diffusion temperature. The result is an increase of the lifetime of the minority carriers in the silicon wafers and an increase in efficiency of the solar cells.

IPC Classes  ?

• H01L 31/18 - Processes or apparatus specially adapted for the manufacture or treatment of these devices or of parts thereof
• H01L 21/225 - Diffusion of impurity materials, e.g. doping materials, electrode materials, into, or out of, a semiconductor body, or between semiconductor regionsRedistribution of impurity materials, e.g. without introduction or removal of further dopant using diffusion into, or out of, a solid from or into a solid phase, e.g. a doped oxide layer

Abstract

The present invention provides a chemical surface cleaning method for textured crystalline silicon wafers, obtained by modifying a standard chemical cleaning method, RCA. In the method according to the invention, chemical cleaning comprises isotropic etching in CP4 etch, followed by immersion of the silicon wafers in the RCA-2 solution. Planarisation increases chemical gettering and does not alter the structure of the micropyramids, since immersion time is short and controlled, of preferably only 10 seconds. Among other technical advantages, the method according to the invention increases by at least 175% the minority carrier lifetime and decreases processing time by approximately 9 minutes.

IPC Classes  ?

• C01B 33/023 - Preparation by reduction of silica or silica-containing material
• C09K 13/04 - Etching, surface-brightening or pickling compositions containing an inorganic acid
• H01L 21/306 - Chemical or electrical treatment, e.g. electrolytic etching

Abstract

Erwinia carotovora, one of the principal agents in causing diseases in potatoes.

IPC Classes  ?

• C12N 1/06 - Lysis of microorganisms
• A01N 63/02 - Substances produced by, or obtained from, microorganisms or animals
• A01N 63/00 - Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
• A01G 13/00 - Protection of plants
• A01N 25/00 - Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of applicationSubstances for reducing the noxious effect of the active ingredients to organisms other than pests

Abstract

The present invention is a method for obtaining a formulation of resveratrol and rice bran oil. The resulting product in the form of an oil or solid proves to increase the therapeutic potential of resveratrol by the synergistic action of the components of the rice oil. The product obtained through the method of the invention is an active principle which, when incorporated in nutraceutical and/or pharmaceutical compositions, provides antioxidant, anti-inflammatory, antiviral, cardioprotective, neuroprotective and/or cancer chemoprotective action, besides protecting against infections and ischemia, reducing obesity, and preventing illnesses of old age.

IPC Classes  ?

• A61K 31/045 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates
• A61K 31/715 - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkagesDerivatives thereof, e.g. ethers, esters
• A61K 36/88 - Liliopsida (monocotyledons)
• A23D 9/007 - Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
• A23D 9/06 - Preservation of finished products
• A23L 1/30 - containing additives (A23L 1/308 takes precedence);;
• A61K 8/34 - Alcohols
• A61K 8/92 - Oils, fats or waxesDerivatives thereof, e.g. hydrogenation products
• A61K 31/05 - Phenols
• A61Q 19/00 - Preparations for care of the skin
• A61K 31/724 - Cyclodextrins

Abstract

This invention provides a natural solvent-based adhesive composition for tires; a mix to prepare adhesive compositions; a preactivation compound for tires; processes to obtain said compositions or mix; or the use of said compounds in bonding tires; and bonding and preactivation processes for tires. The objects of the invention provide industrial solutions that, while introducing a considerable reduction in environmental impact in their preparation and use, provide better health conditions for the professionals who work in the tire bonding industry.

IPC Classes  ?

• C08K 5/00 - Use of organic ingredients
• C08K 5/05 - AlcoholsMetal alcoholates
• C08K 5/06 - EthersAcetalsKetalsOrtho-esters
• C09B 67/00 - Influencing the physical, e.g. the dyeing or printing, properties of dyestuffs without chemical reaction, e.g. by treating with solventsProcess features in the making of dyestuff preparationsDyestuff preparations of a special physical nature, e.g. tablets, films
• C08K 3/00 - Use of inorganic substances as compounding ingredients
• B29D 30/00 - Producing pneumatic or solid tyres or parts thereof
• B05D 5/10 - Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an adhesive surface
• B01F 1/00 - Dissolving

Abstract

A force modulating apparatus for minimizing and/or blocking forces such as the Coriolis force, gravitational, and centrifugal force, simulating the environment of the cosmos. A stabilizing method for material with respect to light and the structure of atoms.

IPC Classes  ?

• B64G 7/00 - Simulating cosmonautic conditions, e.g. for conditioning crews
• G09B 23/06 - Models for scientific, medical, or mathematical purposes, e.g. full-sized device for demonstration purposes for physics
• G09B 23/12 - Models for scientific, medical, or mathematical purposes, e.g. full-sized device for demonstration purposes for physics for statics or dynamics of liquids or gases

Abstract

The present invention provides an adapter device for extension of mini-plates used in orthodontic treatments, which extends the plate into more forward or more rearward and upper or lower positions and also attaches orthodontic accessories, and it may be used for various skeletal anchorage systems available on the market. The present invention also provides pliers for attachment of the device and a method for extension and attachment of mini-plates, comprising the use of the adapter devices according to the present invention.

IPC Classes  ?

• A61C 8/00 - Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereonDental implantsImplanting tools
• A61C 7/04 - Tools for manipulating or working with an orthodontic appliance plier type

Abstract

The present invention describes a pharmaceutical composition and a method for preventing and/or reducing hepatotoxicity associated with a treatment for tuberculosis, reducing the duration of the treatment and avoiding the creation of resistant Mycobacterium tuberculosis strains. The pharmaceutical formulation according to the present invention contains resveratrol, a tuberculostatic agent, and a pharmaceutically acceptable carrier. The present invention pertains to the fields of chemistry, pharmacy and medicine.

IPC Classes  ?

• A61K 31/05 - Phenols
• A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
• A61P 31/06 - Antibacterial agents for tuberculosis

Abstract

The present invention relates to a method for preparing an aqueous anti-microbial solution containing chlorhexidine digluonate and tartaric acid for use with an odontological or orthodontic glass ionomer cement, and to an aqueous anti-microbial solution substantially improved by the addition of up to 18% chlorhexidine digluconate and up to 11% tartaric acid.

IPC Classes  ?

• A01N 47/44 - GuanidineDerivatives thereof
• A01N 29/04 - Halogen directly attached to a carbocyclic ring system
• A01N 37/04 - Saturated carboxylic acids or thio-analogues thereofDerivatives thereof polybasic
• A61K 6/06 - Use of inorganic cements

Abstract

Erwinia carotovora, one of the principal agents in causing diseases in potatoes.

IPC Classes  ?

• A01N 63/02 - Substances produced by, or obtained from, microorganisms or animals

Abstract

The present invention is a process for producing a formulation containing resveratrol and rice bran oil. The oil or solid end-product is intended to enhance the therapeutic potential of resveratrol via the synergistic action of the rice oil components. The product obtained from the process according to the invention is an active principle which, when used in nutraceutical and/or pharmaceutical compositions, has an antioxidant, anti-inflammatory, antiviral, cardioprotective, neuroprotective and/or cancer chemopreventive action, and also protects against infections and ischemia, reduces obesity and prevents age-related diseases.

IPC Classes  ?

• A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
• A61K 8/34 - Alcohols
• A61K 8/36 - Carboxylic acidsSalts or anhydrides thereof
• A61K 8/97 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from algae, fungi, lichens or plantsCosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof
• A61P 25/24 - Antidepressants
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]

Abstract

The present invention provides an adhesive composition for footwear or parts of footwear, based on natural solvents selected from the terpenes, a method for producing this composition and a method for glueing footwear or parts of footwear using this composition. The subject matter of the invention provides industrial solutions which, at the same time, considerably reduce the environmental impact of production and use, and improve sanitary conditions for workers who glue footwear or parts of footwear.

IPC Classes  ?

• C09J 107/00 - Adhesives based on natural rubber
• C09J 121/00 - Adhesives based on unspecified rubbers
• C08J 3/22 - Compounding polymers with additives, e.g. colouring using masterbatch techniques
• B29C 65/54 - Applying the adhesive between pre-assembled parts

Abstract

The present invention provides an adhesive composition for tyres, based on natural solvents selected from the terpenes, a method for producing this composition and a method for glueing tyres using this composition. The subject matter of the invention provides industrial solutions which, at the same time, considerably reduce the environmental impact of production and use, and improve sanitary conditions for workers who glue tyres.

IPC Classes  ?

• C09J 107/00 - Adhesives based on natural rubber
• C09J 121/00 - Adhesives based on unspecified rubbers
• C08J 3/22 - Compounding polymers with additives, e.g. colouring using masterbatch techniques
• B29C 65/54 - Applying the adhesive between pre-assembled parts

Abstract

The present invention relates to a force modulating apparatus, more specifically to an apparatus for minimising and/or cancelling forces such as the Coriolis, gravitational and centrifugal forces, thus simulating outer space conditions. In addition, the present invention relates to a method for stabilising matter in respect of light and the atomic structure.

IPC Classes  ?

• G09B 23/12 - Models for scientific, medical, or mathematical purposes, e.g. full-sized device for demonstration purposes for physics for statics or dynamics of liquids or gases
• G09B 23/38 - Models for scientific, medical, or mathematical purposes, e.g. full-sized device for demonstration purposes for botany
• B64G 7/00 - Simulating cosmonautic conditions, e.g. for conditioning crews

Abstract

The present invention describes a process for producing biopolymer membranes and the membranes produced by this process. In particular, the biopolymer membranes according to the present invention comprise poly(urethane-caprolactone) and can be used for nerve and bone regeneration.

IPC Classes  ?

• C08G 18/08 - Processes
• C08G 63/08 - Lactones or lactides
• C08G 63/82 - Preparation processes characterised by the catalyst used
• A61L 27/18 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
• A61L 27/34 - Macromolecular materials

Abstract

The present invention relates to a remote environmental monitoring method and apparatus. In particular, the present invention provides a system for locally detecting changes in the environment, which are then transmitted via satellite for analysis or processing.

IPC Classes  ?

• H04L 29/08 - Transmission control procedure, e.g. data link level control procedure
• G06F 19/00 - Digital computing or data processing equipment or methods, specially adapted for specific applications (specially adapted for specific functions G06F 17/00;data processing systems or methods specially adapted for administrative, commercial, financial, managerial, supervisory or forecasting purposes G06Q;healthcare informatics G16H)
• H04L 12/56 - Packet switching systems
• H04W 84/18 - Self-organising networks, e.g. ad hoc networks or sensor networks

Abstract

Disclosed is a method for preparing a formulation of resveratrol and rice bran oil. The resultant product in the form of an oil or solid aims at increasing the therapeutic potential of resveratrol by synergy with the rice oil components. The product obtained by the claimed method is an active principle which, when incorporated into nutraceutical compositions, has anti-oxidant, anti-inflammatory, anti-viral, cardioprotective, neuroprotective and/or cancer chemopreventive effects, besides protecting against infection and ischaemia, reducing obesity and preventing diseases due to ageing.

IPC Classes  ?

• A23D 9/007 - Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
• A23L 1/30 - containing additives (A23L 1/308 takes precedence);;
• A61K 31/05 - Phenols
• A61K 36/899 - Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
• A61K 8/34 - Alcohols
• A61K 8/92 - Oils, fats or waxesDerivatives thereof, e.g. hydrogenation products
• A61P 9/00 - Drugs for disorders of the cardiovascular system
• A61P 17/18 - Antioxidants, e.g. antiradicals

Abstract

A process for the germination and/or modulation of plant development by subjecting plants to simulated hypergravity conditions as a way of increasing efficiency and speed of plant development and/or germination.

IPC Classes  ?

• A01G 1/00 - Horticulture; Cultivation of vegetables (labels or name-plates G09F 3/00, G09F 7/00)

Abstract

The invention induces an increase in the resistance of potato plants, without apparent toxicity for the plant. Preliminary experiments indicate that the increase in metabolism of plants efficiently fosters (above 60%) the reduction of the development of the pathogenic phytobacteria, Erwinia carotovora, one of the principal agents in causing diseases in potatoes.

IPC Classes  ?

• A01N 63/02 - Substances produced by, or obtained from, microorganisms or animals

Abstract

The present invention comprises an automated external defibrillator and its method of operation. In particular, the defibrillator is portable and easy to operate. It automatically performs the analysis of the cardiac rhythm and guides the operator by voice and/or visual signals with respect to the several steps until the use of the electric shock to recuperate the patient. In particular, the use of this equipment does not require that the operator is a physician.

IPC Classes  ?

• A61N 1/39 - Heart defibrillators

Abstract

The present invention discloses a device for incubating fish and other test specimens and a farming process for fish and other animals, both of which use an innovative concept for creating a microgravity environment on earth as a way to increase the efficiency of farming/development of fish and other animals in different stages of development.

IPC Classes  ?

• C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
• A01K 61/00 - Culture of aquatic animals

Abstract

The present discloses a method for detection and correction of errors, based on the proposition of multidimensional error correcting code, presenting the first example of implementation of MECC called BCHMD, that employ the BCH or BCH algebraic in each dimension of the set of symbols in the encoder and decoder sides of the communication system, in the error correcting code stage. Especially the described method claimed by the present invention embraces bits in different dimensions, which improves performance, speed and capacity in the ECC.

IPC Classes  ?

• H03M 13/00 - Coding, decoding or code conversion, for error detection or error correctionCoding theory basic assumptionsCoding boundsError probability evaluation methodsChannel modelsSimulation or testing of codes

Abstract

The present invention provides products having resveratrol with high water solubility and nutraceutical and/or phytotherapic compositions having said substances. The processes for obtaining them include the solubility increase of the polyphenol corresponding to a resveratrol compound, preferably trans- resveratrol in water, by its complexation with cyclodextrin under specific conditions that favor thermodynamic equilibrium. The products of the invention present high solubility and purity in aqueous medium, being, therefore, useful to prepare nutraceutical compositions (pharmaceutical and/or alimentary) with antioxidant, anti-inflammatory, antiviral, antidiabetics, cardioprotective, neuroprotective, chemoprotective activities; besides protecting against infections and ischemia, reducing obesity, and preventing aging. Phytotherapic compositions useful to the same therapeutical activities, prepared from the complex of resveratrol and cyclodextrin compound, preferably beta- cyclodextrin/trans-resveratrol, are also provided.

IPC Classes  ?

• A61K 31/05 - Phenols
• A61K 47/40 - CyclodextrinsDerivatives thereof

Abstract

The present invention provides a process for the germination and/or modulation of plant development using the inventive concept of subjecting plants to simulated hypergravity conditions as a way of increasing efficiency and speed of plant development and/or germination.

IPC Classes  ?

• A01H 3/00 - Processes for modifying phenotypes
• A01C 1/00 - Apparatus, or methods of use thereof, for testing or treating seed, roots, or the like, prior to sowing or planting
• A01G 7/00 - Botany in general

Abstract

The present invention provides a pharmaceutical product and a process for bone regeneration and neoformation, which uses sirtuin modulators such as resveratrol and/or trans-resveratrol. Among the several advantages of the invention, worth of notice is the substantial acceleration in the process of integration of biomaterials to the body, substantially shortening the recovery period of the injured or lost organ.

IPC Classes  ?

• A61K 31/05 - Phenols
• A61P 19/08 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
• A61P 19/10 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Abstract

The present invention provides effective means by which nucleotide sequences of any organism can be used as standards for detection/quantification of these organisms. The reference standards of this invention are particularly useful to perform absolute quantification of nucleotide sequences and/or microorganisms from DNA found in biological samples, biological fluids, food and cosmetics, with the additional use of the Fluorescence-associated Polymerase Chain Reaction (real-time PCR) technique. The applications of the invention include research involving quantification of nucleic acids (DNA/RNA), as well as DNA/RNA of organisms such as viral and bacterial pathogens. Therefore, this invention is useful in diagnosis of infectious diseases, food industry and cosmetic industry. This invention also provides an improved method for detection/quantification of nucleotide sequences and a kit.

IPC Classes  ?

• C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
• C12Q 1/68 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions involving nucleic acids